Capillus Leads Innovation & Awareness at the 77th AAD Annual Conference

Capillus Leads Innovation & Awareness at the 77th AAD Annual Conference

Capillus, LLC is committed to staying abreast of medical advancements and research in hair restoration to increase awareness of biomodulation as a treatment method for hair loss.

The company showcased its premiere medical laser devices to an international audience of physicians specializing in dermatology at the American Academy of Dermatology 2019 AAD Annual Meeting in Washington, D.C.

Feedback from both physicians and customers is continuously taken into consideration by the Capillus team to innovate, upgrade and improve the product line. The company is committed to bringing awareness of laser therapy as a medical treatment for androgenic alopecia, which has long been used by medical professionals in hair restoration specialties but is still relatively new to dermatology. Capillus manufactures its devices from its ISO13485:2016 certified headquarters in Miami, Florida.

Also featured at the AAD annual meeting, Capillus announced their expanded Cap+ brand line of clinical hair care products, which contains natural ingredients to cleanse, exfoliate, and moisturize hair while promoting overall scalp health.

The expanded line of Cap+ products now includes a hair health supplement and 2% minoxidil for women, in addition to its 5% minoxidil for men and other hair care products. The popular Cap+ Bundle, which includes all Cap+ products, is applied to remove build-up in hair, restore vitality to lock in moisture, reduce inflammation while lubricating hair follicles as well as repair hair damage.

Capillus also congratulates Dr. Janice Lima-Maribona, a Miami, FL Dermatologist, for winning the CapillusRx (valued at $3,499) at the AAD annual meeting. The company generated a lot of buzz and interest from physicians specialized in dermatology with hair loss patients from around the world. Capillus urges interested physicians and specialists to become a part of the Capillus Physician Network, to contact the company directly at (844)-280-4680.

In furthering their commitment to hair science and research, Capillus will also be participating in the upcoming World Congress for Hair Research taking place abroad in Barcelona on April 24th, 2019. The congress will be a comprehensive, international hair research meeting for the advancement of knowledge in hair growth.

The company’s involvement will once again be integral to staying ahead of the curve with new advancements, research, and techniques for the development of hair growth in connection with international hair loss physicians.

About Capillus, LLC

Capillus, LLC offers both prescription as well as over-the-counter hair regrowth products and medical devices for both men and women suffering from hair loss. The Capillus premier product lines include low-level laser therapy (LLLT) devices that are FDA-cleared and manufactured in the US under the highest-quality certification standard for the medical device industry (ISO13485). Capillus also offers additional non-prescription clinical hair products for hair and scalp health under the Cap+ and RXCap+ brand. Capillus products are available directly to the public for at-home use and also to their network of physicians for office use.

For more information, visit: https://www.capillus.com/

Capillus Leads Innovation & Awareness at the 77th AAD Annual Conference

Source

 

Previous Posts

Posted in: